We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$430M
Cap. Flow
+$532M
Cap. Flow %
13.96%
Top 10 Hldgs %
44.45%
Holding
75
New
7
Increased
31
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
ALIT icon
Alight
ALIT
+$70.1M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$67.8M
3
MD icon
Pediatrix Medical
MD
+$59.9M
4
TDOC icon
Teladoc Health
TDOC
+$56.5M
5
CAR icon
Avis
CAR
+$53.3M

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$69.7M
2
ATMU icon
Atmus Filtration Technologies
ATMU
+$36.5M
3
PARR icon
Par Pacific Holdings
PARR
+$28.6M
4
PLYA
Playa Hotels & Resorts
PLYA
+$27.5M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 49.51%
2 Technology 9.09%
3 Industrials 7.78%
4 Financials 7.37%
5 Utilities 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSTK icon
51
Shutterstock
SSTK
$205M
$14.8M 0.39%
+381,631
New +$15.5M
ARDX icon
52
Ardelyx
ARDX
$1.02B
$13.5M 0.35%
1,816,585
– –
KOP icon
53
Koppers
KOP
$858M
$13.4M 0.35%
361,487
-211,171
-37% -$9.85M
OABI icon
54
OmniAb
OABI
$494M
$10.7M 0.28%
2,850,588
– –
TSAT icon
55
Telesat
TSAT
$921M
$8.73M 0.23%
959,764
– –
PLYA
56
DELISTED
Playa Hotels & Resorts
PLYA
$8.71M 0.23%
1,037,788
-3,118,052
-75% -$27.5M
PTGX icon
57
Protagonist Therapeutics
PTGX
$9.83B
$6.86M 0.18%
198,059
– –
RVNC
58
DELISTED
Revance Therapeutics, Inc.
RVNC
$6.83M 0.18%
2,656,847
– –
MYPS icon
59
PLAYSTUDIOS Inc
MYPS
$77.1M
$5.61M 0.15%
2,711,190
+342,413
+14% +$805K
SPRY icon
60
ARS Pharmaceuticals
SPRY
$585M
$5.44M 0.14%
639,203
– –
ABUS icon
61
Arbutus Biopharma
ABUS
$899M
$5.19M 0.14%
+1,681,090
New +$5.04M
BCYC
62
Bicycle Therapeutics
BCYC
$287M
$4.16M 0.11%
205,423
– –
OVID icon
63
Ovid Therapeutics
OVID
$485M
$4.09M 0.11%
5,315,969
– –
HOWL icon
64
Werewolf Therapeutics
HOWL
$18.2M
$3.25M 0.09%
1,333,893
-287,141
-18% -$1.38M
TXMD icon
65
TherapeuticsMD
TXMD
$24M
$1.92M 0.05%
1,192,191
– –
IMVT icon
66
Immunovant
IMVT
$8.69B
$1.55M 0.04%
+58,624
New +$1.67M
VINC
67
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$94.7K ﹤0.01%
5,844
– –
ATMU icon
68
Atmus Filtration Technologies
ATMU
$4.07B
– –
-1,132,056
Closed -$36.5M
CGEM icon
69
Cullinan Oncology
CGEM
$1.26B
– –
-626,929
Closed -$10.7M
IBIT icon
70
iShares Bitcoin Trust
IBIT
$47.2B
– –
-1,722,497
Closed -$69.7M
NUVL
71
DELISTED
Nuvalent
NUVL
– –
-261,874
Closed -$19.7M
PARR icon
72
Par Pacific Holdings
PARR
$3.76B
– –
-772,384
Closed -$28.6M
SWTX
73
DELISTED
SpringWorks Therapeutics
SWTX
– –
-426,768
Closed -$21M
XERS icon
74
Xeris Biopharma Holdings
XERS
$1.54B
– –
-310,959
Closed -$687K
1 2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q2 2024 Portfolio in Review

As of Q2 2024, Rubric Capital Management (New York) held 75 positions worth $3.81B, up 13% from $3.38B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rubric Capital Management (New York) deployed $532M of net new capital in Q2 2024, opening 7 new positions and adding to 31 existing holdings. Its largest new stake was Alight: 421,153 shares worth $62.2M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Playa Hotels & Resorts, an estimated $27.5M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2024 buy was Alight: 421,153 shares worth $62.2M.
  • Rubric Capital Management (New York) added most to Pediatrix Medical in Q2 2024, an estimated $59.9M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2024 reduction was Playa Hotels & Resorts, cutting an estimated $27.5M.
  • Rubric Capital Management (New York) fully exited iShares Bitcoin Trust in Q2 2024, selling an estimated $69.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 44% of its $3.81B portfolio in Q2 2024.
  • Rubric Capital Management (New York) opened 7 new positions and closed 7 in Q2 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $3.81B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2024, filed 13 Aug 2024.